Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity ...

Thermo Fisher stock has seen modest organic growth and trades at 25x earnings after pricey acquisitions. Here's what ...

Plus, the Science Center announced its ninth Capital Readiness cohort, meet the winners of Hopeworks’ young entrepreneurs pitch competition and more power moves.

Thermo Fisher Scientific Inc. (NYSE:TMO) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15, ...

Waltham, Massachusetts-based Thermo Fisher Scientific Inc. (TMO) provides life sciences solutions, analytical instruments, ...

Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...

Artisan Partners, an investment management company, released its “Artisan Value Fund” third-quarter 2025 investor letter. A ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing up its biologics production business through a $4.1 billion acquisition. The buyout target is ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its goodie bag, the company ...